Conferences
GU Cancers Symposium 2014 - Is surveillance the standard treatment for clinical stage I germ cell tumor? - Session Highlights
February 3, 2014
GU Cancers Symposium 2014 - A decade in review: Building blocks in the progress in management of urothelial carcinomas - Session Highlights
February 3, 2014
GU Cancers Symposium 2014 - A decade in review: Penile, urethral, and testicular cancers - Session Highlights
February 3, 2014
GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Session Highlights
February 3, 2014
GU Cancers Symposium 2014 - Evaluation of outcomes following centralization of cystectomy services in the United Kingdom - Session Highlights
February 3, 2014
GU Cancers Symposium 2014 - The Cancer Genome Atlas (TCGA) bladder cancer update - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - Next generation sequencing technologies: Advancing therapy for urothelial carcinoma - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - Preclinical models for bladder cancer - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - Keynote Lecture: Evolution of prostate cancer genomes - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - Multimodal management of urothelial carcinoma - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - A pooled analysis of RTOG 9906 and 0233 - Session Highlights
February 1, 2014
GU Cancers Symposium 2014 - Practical use of molecular markers in the management of bladder cancer - Session Highlights
February 1, 2014